Question 1

What is the catalog number for CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (FITC) discontinued?

Accepted Answer

The catalog number for CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (FITC) discontinued is 033152-FITC.

Question 2

What sizes are available for CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (FITC) discontinued?

Accepted Answer

CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (FITC) discontinued is available in the following size(s): 200 µL.

Question 3

Is CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (FITC) discontinued in stock?

Accepted Answer

CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (FITC) discontinued

Selected Variant

033152-FITC

Size: 200 µL

Product Specifications

Clonality

Pab

Question 4

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 5

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 6

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.